Which has grown faster, DGX or MRNA?

Over the past five years, DGX grew revenue faster — DGX at a 1.76% CAGR versus MRNA at -2.60%.

Does DGX or MRNA pay a bigger dividend?

DGX pays a dividend (1.58% yield) while MRNA does not currently pay one.

Is DGX or MRNA more profitable?

DGX runs the higher net margin — DGX at 9.08% versus MRNA at -143.55%.

Which has been the better investment, DGX or MRNA?

Over the past 5-year, DGX delivered the higher annualized total return — DGX at 12.28% versus MRNA at -22.95%. Past performance doesn't predict future results.

Quest Diagnostics Incorporated (DGX) vs Moderna, Inc. (MRNA)

DGX leads on 8 of 9 compared metrics.

A side-by-side comparison of Quest Diagnostics Incorporated and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

DGX

Quest Diagnostics Incorporated

Total return — DGX vs MRNA

growth of $100 · last 8y

DGX +135.5%MRNA +221.2%MRNA compounded faster

DGX MRNA

DGX vs MRNA: by the numbers

•MRNA is the larger company ($23.71B vs $22.83B market cap).
•DGX is profitable (9.08% net margin) while MRNA runs a net loss (-143.55%).
•DGX grew revenue faster over the past five years (1.76% vs -2.60% CAGR).
•DGX pays a dividend (1.58% yield) while MRNA does not currently pay one.

Which is better, DGX or MRNA?

Metric tally: DGX 8 · MRNA 1

It depends on what you're optimizing for:

GrowthDGX(faster 5Y revenue CAGR)

QualityDGX(higher ROIC)

Metrics side by side

Valuation

Metric	DGX	MRNA
P/E ratio	22.79	—
Forward P/E	17.67	—
P/S ratio	2.05●	10.61
P/B ratio	3.14	3.19
PEG ratio	1.43	—
EV / EBITDA	13.98	—
FCF yield	5.74%	—

Profitability

Metric	DGX	MRNA
Gross margin	33.23%●	-13.89%
Operating margin	14.31%●	-153.35%
Net margin	9.08%●	-143.55%
ROE	13.90%●	-43.12%
ROIC	8.43%●	-29.70%

Dividends

Metric	DGX	MRNA
Dividend yield	1.58%	—
Payout ratio	36.75%	—

Growth (annualized)

Metric	DGX	MRNA
Revenue CAGR (5Y)	1.76%●	-2.60%
EPS CAGR (5Y)	-3.65%	—
FCF CAGR (5Y)	-8.51%	126.92%●
Total return CAGR (5Y)	11.90%●	-22.95%

Frequently asked

Which is better, DGX or MRNA?: It depends on your goal. growth: DGX (faster 5Y revenue CAGR); quality: DGX (higher ROIC). Across all compared metrics, DGX leads 8 to 1.
Which has grown faster, DGX or MRNA?: Over the past five years, DGX grew revenue faster — DGX at a 1.76% CAGR versus MRNA at -2.60%.
Does DGX or MRNA pay a bigger dividend?: DGX pays a dividend (1.58% yield) while MRNA does not currently pay one.
Is DGX or MRNA more profitable?: DGX runs the higher net margin — DGX at 9.08% versus MRNA at -143.55%.
Which has been the better investment, DGX or MRNA?: Over the past 5-year, DGX delivered the higher annualized total return — DGX at 12.28% versus MRNA at -22.95%. Past performance doesn't predict future results.

Go deeper

Full DGX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Quest Diagnostics P/E ratio Moderna P/E ratio Quest Diagnostics dividend yield Moderna dividend yield Quest Diagnostics ROE Moderna ROE Quest Diagnostics operating margin Moderna operating margin Quest Diagnostics revenue growth Moderna revenue growth Quest Diagnostics free cash flow Moderna free cash flow

Quest Diagnostics & Moderna appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.